Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.780
-0.130 (-6.81%)
Mar 31, 2025, 3:51 PM EDT - Market open
Whitehawk Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 25.98 | 24.35 | 15.22 | 1.12 | 14.58 | Upgrade
|
| Revenue Growth (YoY) | 6.69% | 60.05% | 1258.57% | -92.32% | 1846.60% | Upgrade
|
| Cost of Revenue | 54.05 | 51.74 | 34 | 19.67 | 15.01 | Upgrade
|
| Gross Profit | -28.07 | -27.38 | -18.78 | -18.55 | -0.43 | Upgrade
|
| Selling, General & Admin | 36.75 | 44.55 | 40.18 | 18.51 | 2.12 | Upgrade
|
| Operating Expenses | 36.75 | 44.55 | 40.18 | 18.51 | 2.12 | Upgrade
|
| Operating Income | -64.82 | -71.93 | -58.96 | -37.06 | -2.55 | Upgrade
|
| Interest Expense | -0.15 | -0.23 | -0.23 | -0.67 | -0.82 | Upgrade
|
| Interest & Investment Income | 3.93 | 6.4 | 2.4 | 0.01 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -61.05 | -65.77 | -56.79 | -37.71 | -3.32 | Upgrade
|
| Merger & Restructuring Charges | -2.64 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | -3.72 | -74.16 | - | Upgrade
|
| Other Unusual Items | - | - | - | 1.78 | -0.15 | Upgrade
|
| Pretax Income | -63.69 | -65.77 | -60.51 | -110.09 | -3.48 | Upgrade
|
| Income Tax Expense | - | - | - | 0 | 0 | Upgrade
|
| Net Income | -63.69 | -65.77 | -60.51 | -110.09 | -3.48 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 0.65 | 0.99 | Upgrade
|
| Net Income to Common | -63.69 | -65.77 | -60.51 | -110.74 | -4.47 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 27 | 23 | 9 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 27 | 23 | 9 | 3 | Upgrade
|
| Shares Change (YoY) | 0.42% | 19.58% | 152.27% | 250.99% | -68.28% | Upgrade
|
| EPS (Basic) | -2.36 | -2.44 | -2.69 | -12.41 | -1.76 | Upgrade
|
| EPS (Diluted) | -2.36 | -2.44 | -2.69 | -12.41 | -1.76 | Upgrade
|
| Free Cash Flow | - | -63.64 | -50.08 | -22.47 | -12.7 | Upgrade
|
| Free Cash Flow Per Share | - | -2.36 | -2.23 | -2.52 | -5.00 | Upgrade
|
| Gross Margin | -108.04% | -112.44% | -123.43% | - | -2.94% | Upgrade
|
| Operating Margin | -249.47% | -295.36% | -387.47% | -3309.02% | -17.48% | Upgrade
|
| Profit Margin | -245.13% | -270.04% | -397.69% | -9887.23% | -30.62% | Upgrade
|
| Free Cash Flow Margin | - | -261.29% | -329.15% | -2006.16% | -87.11% | Upgrade
|
| EBITDA | -64.63 | -71.76 | -58.8 | -36.96 | -2.54 | Upgrade
|
| EBITDA Margin | -248.72% | -294.67% | - | - | -17.42% | Upgrade
|
| D&A For EBITDA | 0.19 | 0.17 | 0.16 | 0.11 | 0.01 | Upgrade
|
| EBIT | -64.82 | -71.93 | -58.96 | -37.06 | -2.55 | Upgrade
|
| EBIT Margin | -249.47% | -295.36% | - | - | -17.48% | Upgrade
|
| Revenue as Reported | 25.98 | 24.35 | 15.22 | 1.12 | 14.58 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.